1.The Latest Research Progress of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients --Review.
Xiao-Sui LING ; Hai-Ping HE ; Li-Hua ZHANG ; Fan LI
Journal of Experimental Hematology 2023;31(4):1233-1236
Multiple myeloma (MM) is a malignant proliferative disease of plasma cells. Bone marrow mesenchymal stem cells (MSC) play an important role in the progression of MM. Compared with normal donor derived MSC (ND-MSC), MM patients derived MSC (MM-MSC) exhibit abnormalities in genes, signaling pathways, protein expression levels and cytokines secreted by themselves. Moreover, the exosomes of MM-MSC can interact with the bone marrow microenvironment. The above reasons can lead to MM cell proliferation, chemoresistance, impaired osteogenic differentiation of MM-MSC, and affect the immunomodulatory capacity of MM patients. In order to further understand the pathogenesis and related influencing factors of MM, this paper reviews the latest research progress of MM-MSC.
Humans
;
Multiple Myeloma/pathology*
;
Osteogenesis
;
Mesenchymal Stem Cells
;
Cell Differentiation
;
Bone Marrow/metabolism*
;
Bone Marrow Cells/metabolism*
;
Tumor Microenvironment
2.IL-32 mRNA Expression of Bone Marrow Stromal Cells and Its Correlation with Cell Apoptosis in Patients with Myelodysplastic Syndrome.
Yuan-Yu ZHANG ; Li XU ; Da-Qi LI ; Jian-Hua SHAO ; Ping CHEN ; Hong-Yu ZHAO ; Xue-Bin DONG ; Lin-Ping GU ; Wei WU
Journal of Experimental Hematology 2016;24(3):773-778
OBJECTIVETo investigate the IL-32 mRNA expression of bone marrow stromal cells and its correlation with apoptosis of bone marrow mononuclear cells in patients with myelodysplastic syndrome (MDS).
METHODSBone marrow samples from 26 MDS patients and 10 iron deficiency anemia (IDA, as control) patients were collected, RT-PCR was used to detect the IL-32 mRNA expression of bone marrow stromal cells, and the apoptosis of bone marrow mononuclear cells was detected by flow cytometry with Annexin V-FITC/PI dowble staining. The born marrow lymphocytes and NK cells were detected by means of direct immunofluorescence labeling whole blood hemolysis and flow cytometry.
RESULTSIL-32 mRNA expression of bone marrow stromal cells in the MDS patients was significantly higher than that of control group, the IL-32 mRNA expression of bone marrow stromal cells in patients with RA, RAS and RCMD was significantly higher than that in patients with RAEB. There was no obvious difference between RAEB and the control groups. The apoptosis of bone marrow mononuclear cells in MDS group was significantly higher than that in the control group, the apoptosis of bone marrow mononuclear cells in patients with RA, RAS and RCMD was significantly higher than that in RAEB. There was no significant difference between RAEB group and control group. The IL-32 mRNA expression in bone marrow stromal cells significantly correlated with the apoptosis of bone marrow mononuclear cells in MDS patients. The NK cell number in born marrow of MDS patients and the control group had no significant difference.
CONCLUSIONThe expression of IL-32 mRNA in bone marrow stromal cells significantly relates with the apoptosis of MDS cells, and the secretion of IL-32 by bone marrow stromal cells may be one of the reasons for the apoptosis of MDS bone marrow cells. It is speculated that the abnormal MDS bone marrow microenvironment is involved in the apoptosis of bone marrow cells.
Apoptosis ; Bone Marrow Cells ; metabolism ; Flow Cytometry ; Humans ; Interleukins ; metabolism ; Mesenchymal Stromal Cells ; metabolism ; Myelodysplastic Syndromes ; pathology ; RNA, Messenger ; metabolism
3.Application of flow cytometry in detecting dysplasia of myelodysplastic syndromes.
Journal of Experimental Hematology 2013;21(4):1069-1072
Myelodysplastic syndrome (MDS) is a heterogeneous disease characterized by dysplasia and ineffective hematopoiesis. The dysplasia is crucial in the diagnosis of MDS, but the morphologic abnormalities of bone marrow cells are not specific for MDS. When the morphological evaluation of marrow dysplasia and cytogenetics can not give enough informations, for diagnosis of MDS, the application of flow cytometry (FCM) for immunophenotyping in MDS will become particularly important. Multiparametric evaluation of myeloid, monocytic maturation and antigen expression pattern contribute to the identification of two or more aberrancies in MDS cases. FCM evaluation of erythroid dysplasia is particularly difficult, because of the limited availability of specific markers. By analyzing the proteins involved in cellular iron metabolism, MDS erythroid cells present an "iron-loaded" phenotype characterized by increased ferritin contents and reduced transferrin receptor, which reflects the degree of dysplasia assessed by morphology. The proportion of CD34(+) cells increased, abnormal expression of surface antigen is also important. The application of flow cytometry in detecting dysplasia of myelodysplastic syndrome is discussed in this article.
Bone Marrow Cells
;
pathology
;
Erythroid Cells
;
metabolism
;
Flow Cytometry
;
Humans
;
Myelodysplastic Syndromes
;
blood
;
diagnosis
;
pathology
;
Receptors, Transferrin
;
metabolism
4.Research advances on abnormal marrow fibre in leukemia.
Journal of Experimental Hematology 2014;22(1):229-231
The genesis and development of leukemia not only associate to intrinsic factors, but also relate with the fibrous hyperplasia in the bone marrow. This review mainly focuses on the interaction between fiber-producing cells and leukemia cells, the relationship between fibrous hyperplasia and prognosis of leukemia, the regulation of TGF-beta, PDGF and other cytokines, the underlying mechanism of fibrous hyperplasia so as to explore the potential therapeutic targets for improving the prognosis of leukemia.
Bone Marrow
;
pathology
;
Bone Marrow Cells
;
cytology
;
Cell Differentiation
;
Cytokines
;
metabolism
;
Fibroblasts
;
cytology
;
Humans
;
Leukemia
;
pathology
;
Platelet-Derived Growth Factor
;
metabolism
;
Transforming Growth Factor beta
;
metabolism
5.Research advances on drug resistance and anti-apoptosis of leukemic cells associated with bone marrow stromal cells--review.
Journal of Experimental Hematology 2005;13(3):529-533
The bone marrow microenvironment composed of bone marrow cell, their secreted cytokines and extra-cellular medium (ECM), plays an important role in the process of hematopoiesis, hematonosis, apoptosis of malignant blood cells. In this review, the mechanisms for the protection of the leukemiic cells from the drug-induced apoptosis by bone marrow stromal cells and the related progress were summarized.
Apoptosis
;
Apoptosis Regulatory Proteins
;
metabolism
;
Bone Marrow Cells
;
metabolism
;
pathology
;
Drug Resistance, Neoplasm
;
Humans
;
Leukemia
;
metabolism
;
pathology
;
Proto-Oncogene Proteins c-bcl-2
;
metabolism
;
Stromal Cells
;
metabolism
;
pathology
6.Expression of SDF-1 gene in bone marrow mesenchymal stem cells of patients with myelodysplastic syndrome.
Journal of Experimental Hematology 2006;14(2):281-284
This study was aimed to investigate the expression level of stromal cell derived factor-1 gene (SDF-1) in bone marrow mesenchymal stem cells (MSC) of patients with myelodysplastic syndrome (MDS). The MSC from bone marrow samples of MDS patients were isolated, cultured and expanded, the morphology and immunophenotype of MSC were analyzed. The expression levels of SDF-1 and internal reference GAPDH in MSC of MDS patients were detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-RT-PCR) method and were compared with expression levels of healthy donors. The results showed that the expression levels of SDF-1 in MDS patients were significantly different from those in healthy donors (1.53 +/- 0.92 vs 5.51 +/- 0.99) (P < 0.01). SDF-1 gene expression levels in bone marrow MSC of MDS patients were significantly higher than that in MSC derived from healthy donors. It is concluded that the abnormal expression of SDF-1 gene in MSC may influence the regulation of hematopoiesis of the bone marrow microenvironment in MDS patients and it is worthy of further investigation for new clue on etiological mechanism and treatment of MDS.
Adult
;
Aged
;
Bone Marrow Cells
;
metabolism
;
pathology
;
Cells, Cultured
;
Chemokine CXCL12
;
biosynthesis
;
genetics
;
Female
;
Humans
;
Male
;
Mesenchymal Stromal Cells
;
metabolism
;
pathology
;
Middle Aged
;
Myelodysplastic Syndromes
;
genetics
;
metabolism
;
pathology
7.Expressions of c-mpl proteins on CD34+ bone marrow cells and platelets of the patients with polycythemia vera.
Jie BAI ; Zong-Hong SHAO ; Jun SHI ; Hai-Rong JIA ; Juan SUN
Journal of Experimental Hematology 2007;15(5):1061-1064
The objective of this study was to investigate the expressions of TPO receptor (c-mpl) proteins on CD34 positive bone marrow cells (CD34+ BMCs), platelets and the expression of c-mpl mRNA in bone marrow cells of the patients with polycythemia vera (PV). The expressions of c-mpl proteins on CD34+ bone marrow hematopoietic cells of 13 PV patients and 15 normal controls were assessed by bicolor flow cytometry and the expressions of c-mpl proteins on platelets of 15 PV patients and 15 normal controls were assessed by monocolor flow cytometry, and the expressions of c-mpl mRNA in bone marrow hematopoietic cells (BMHCs) were assessed by RT-PCR. The results showed that no difference was found between the expression of c-mpl proteins on CD34+ BMHCs of PV patients (0.99% +/- 0.14%) and that of normal controls (0.92% +/- 0.12%) (p > 0.05). There was no difference too between the expression of c-mpl protein on platelets in PV patients (20.33% +/- 4.84%) and that in normal controls (23.50% +/- 3.64%) (p > 0.05). No difference between the expression of c-mpl mRNA in BMHCs of PV patients and that in normal controls was seen. In conclusion, the expressions of c-mpl proteins on CD34+ BMHCs, platelets and c-mpl mRNA in BMHCs of PV patients were not obviously abnormal.
Antigens, CD34
;
analysis
;
Blood Platelets
;
metabolism
;
Bone Marrow Cells
;
metabolism
;
pathology
;
Hematopoietic Stem Cells
;
metabolism
;
pathology
;
Humans
;
Polycythemia Vera
;
genetics
;
metabolism
;
RNA, Messenger
;
metabolism
;
Receptors, Thrombopoietin
;
metabolism
9.Abnormal expression of PDCD5 in the bone marrow cells of adult acute myeloid leukemia.
Guo-Rui RUAN ; Shan-Shan CHEN ; Xi MA ; Yan CHANG ; Hui WAN ; Jia-Yu FU ; Ya-Zhen QIN ; Jin-Lan LI ; Yan-Rong LIU
Journal of Experimental Hematology 2007;15(3):462-465
The objective of this study was to estimate a novel apoptosis-promoting molecule PDCD5 expression in the bone marrow cells from adult acute myeloid leukemia (AML) for investigation of its significance in the pathogenesis of AML. Flow cytometry assay was used for detection of PDCD5 expression in the different groups of cells from bone marrow of AML patients and normal controls by using 21 monoclonal antibodies with different fluorescent markers. The PDCD5 expressions in bone marrow cells from some AML patients and normal controls were also detected by Western blot. The results showed that the mean PDCD5 fluorescence intensity in bone marrow nucleated cells (MNC) from the bone marrow of 36 untreated AML patients was significantly lower than that from the bone marrow of 30 normal controls (3059 +/- 1392) vs (7432 +/- 1261) (P < 0.01). The mean PDCD5 fluorescence intensity was lower in the marrow granulocytes, monocytes, blast cells, and lymphocytes from untreated AML patients than that from normal (3939 +/- 2121) vs (8367 +/- 1045); (3156 +/- 1635) vs (5917 +/- 2329); (2824 +/- 1592) vs (3998 +/- 2106); (1474 +/- 816) vs (3355 +/- 2042) respectively, (all P < 0.01). Western blot analysis demonstrated that PDCD5 expression was significantly decreased in the AML cells, as compared with normal cells. It is concluded that PDCD5 expression in MNC in untreated AML patients is lower than that in the normal. PDCD5 expression in the marrow granulocytes, monocytes, blast cells, and lymphocytes of untreated AML patients is significantly lower than that in the normal. It suggests that the abnormally low expression of PDCD5 may be involved in the pathogenesis of AML.
Apoptosis
;
physiology
;
Apoptosis Regulatory Proteins
;
metabolism
;
Bone Marrow Cells
;
metabolism
;
Humans
;
Leukemia, Myeloid, Acute
;
metabolism
;
pathology
;
Neoplasm Proteins
;
metabolism
10.Autophagy Activity of CD34+ Cells in MDS Patients and Its Clinical Significance.
Feng JIANG ; Yuan-Yuan WANG ; Jian-Nong CEN ; Zi-Xing CHEN ; Jian-Ying LIANG ; Dan-Dan LIU ; Jin-Lan PAN ; Ming-Qing ZHU ; Su-Ning CHEN
Journal of Experimental Hematology 2016;24(3):779-783
OBJECTIVETo explore the autophagy activity of CD34+ cells in bone marrow of MDS patients and its clinical significance.
METHODSThe activity of autophagy in bone marrow CD34+ cells from 20 MDS patients, 20 non-malignant anemia patients and 5 AML patients admitted in our hospital from October 2012 to March 2014 was detected by flow cytometry (FCM).
RESULTSThe autophagy activity in low risk MDS patients and non-malignant anemia patients were both significantly higher than that in both high risk MDS and AML patients (P<0.05), and more interestingly, the autophagy activity in MDS negatively correlated with World Health Organization classification-based prognostic system (WPSS) score (r=-0.877) .
CONCLUSIONThe autophagy activity CD34+ cells in the patients with MDS is higher than that in AML patients, and negatively correlated with WPSS scores, indicating that the decrease of autophagy activity maybe accelerate the genesis and development of MDS and relate with the prognosis of MDS patients.
Antigens, CD34 ; metabolism ; Autophagy ; Bone Marrow Cells ; cytology ; pathology ; Flow Cytometry ; Humans ; Leukemia, Myeloid, Acute ; pathology ; Myelodysplastic Syndromes ; pathology ; Prognosis